Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111194304B details an enzymatic method for chiral bridged rings. Offers high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103228640B details enzymatic resolution for nebivolol. This reduces waste and avoids HPLC, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN104178546A details high-yield enzymatic resolution for S-1-naphthylethylamine. Offers superior purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.